LINC00426 is a potential immune phenotype-related biomarker and an overall survival predictor in PAM50 luminal B breast cancer

LINC00426 is a potential immune phenotype-related biomarker and an overall survival predictor in PAM50 luminal B breast cancer

Background: Breast cancer (BRCA) represents the most frequent diagnosed malignancy in women worldwide. Despite treatment advances, BRCAs eventually develop resistance to targeted therapies, resulting in poor prognosis. The identification of new biomarkers, like immune-related long non-coding RNAs (l...

Full description

Bibliographic Details
Main Authors: Marco Antonio Fonseca-Montaño, Mireya Cisneros-Villanueva, Isabelle Coales, Alfredo Hidalgo-Miranda
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Genetics
Subjects:
breast cancer
PAM50 subtypes
luminal B
LINC00426
immune-cell infiltration
immune checkpoint genes
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2023.1034569/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2023.1034569/full

Similar Items